AGA Clinical Practice Guidelines on the Management of Mild-to-Moderate Ulcerative Colitis
- PMID: 30576644
- PMCID: PMC6858922
- DOI: 10.1053/j.gastro.2018.12.009
AGA Clinical Practice Guidelines on the Management of Mild-to-Moderate Ulcerative Colitis
Conflict of interest statement
Conflict of interest disclosure: All members were required to complete the disclosure statement. These statements are maintained at the American Gastroenterological Association (AGA) headquarters in Bethesda, Maryland, and pertinent disclosures are published with this report.
Similar articles
-
Mild-to-Moderate Ulcerative Colitis Guideline.Gastroenterology. 2019 Feb;156(3):768. doi: 10.1053/j.gastro.2019.01.037. Epub 2019 Jan 23. Gastroenterology. 2019. PMID: 30684447 No abstract available.
-
AGA Technical Review on the Management of Mild-to-Moderate Ulcerative Colitis.Gastroenterology. 2019 Feb;156(3):769-808.e29. doi: 10.1053/j.gastro.2018.12.008. Epub 2018 Dec 18. Gastroenterology. 2019. PMID: 30576642 Free PMC article. Review.
-
Mild-to-Moderate Ulcerative Colitis (UC) Clinical Decision Support Tool.Gastroenterology. 2019 Feb;156(3):765. doi: 10.1053/j.gastro.2019.01.038. Epub 2019 Jan 23. Gastroenterology. 2019. PMID: 30684448 No abstract available.
-
Budesonide Multimatrix Is Efficacious for Mesalamine-refractory, Mild to Moderate Ulcerative Colitis: A Randomised, Placebo-controlled Trial.J Crohns Colitis. 2017 Jul 1;11(7):785-791. doi: 10.1093/ecco-jcc/jjx032. J Crohns Colitis. 2017. PMID: 28333362 Free PMC article. Clinical Trial.
-
Mesalamine with MMX technology for the treatment of ulcerative colitis.Expert Rev Gastroenterol Hepatol. 2008 Jun;2(3):299-314. doi: 10.1586/17474124.2.3.299. Expert Rev Gastroenterol Hepatol. 2008. PMID: 19072380 Review.
Cited by
-
Real-World Effectiveness and Safety of Carotegrast Methyl in Japanese Patients with Moderately Active Ulcerative Colitis.Inflamm Intest Dis. 2024 Oct 21;9(1):271-282. doi: 10.1159/000541663. eCollection 2024 Jan-Dec. Inflamm Intest Dis. 2024. PMID: 39563683 Free PMC article.
-
Characteristics of Mucosa-Associated Microbiota in Ulcerative Colitis Patients with 5-Aminosalicylic Acid Intolerance.Biomedicines. 2024 Sep 19;12(9):2125. doi: 10.3390/biomedicines12092125. Biomedicines. 2024. PMID: 39335641 Free PMC article.
-
Current Pharmacologic Options and Emerging Therapeutic Approaches for the Management of Ulcerative Colitis: A Narrative Review.Spartan Med Res J. 2024 Sep 9;9(3):123397. doi: 10.51894/001c.123397. eCollection 2024. Spartan Med Res J. 2024. PMID: 39280117 Free PMC article. Review.
-
"Two-birds-one-stone" oral nanotherapeutic designed to target intestinal integrins and regulate redox homeostasis for UC treatment.Sci Adv. 2024 Jul 26;10(30):eado7438. doi: 10.1126/sciadv.ado7438. Epub 2024 Jul 24. Sci Adv. 2024. PMID: 39047093 Free PMC article.
-
Efficacy and safety of BaitouWeng decoction for ulcerative colitis: A meta-analysis of randomized and controlled trials.Medicine (Baltimore). 2024 Jul 5;103(27):e38704. doi: 10.1097/MD.0000000000038704. Medicine (Baltimore). 2024. PMID: 38968514 Free PMC article.
References
-
- Schroeder KW, Tremaine WJ, Ilstrup DM. Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study. N Engl J Med 1987;317:1625–9. - PubMed
-
- Dias CC, Rodrigues PP, da Costa-Pereira A, et al. Clinical predictors of colectomy in patients with ulcerative colitis: systematic review and meta-analysis of cohort studies. J Crohns Colitis 2015;9:156–63. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
